RESUMEN
Introduction: during the second wave of the COVID-19 pandemic in Mozambique, there was a surge in pediatric hospitalizations at a time when there was relatively little evidence, but significant concern about clinical outcomes in African children, particularly in higher-risk infants requiring, and health system capacity to respond. Methods: a retrospective cohort study was conducted for patients 1-12 months of age admitted to the Breastfeeding ward at Hospital Central de Maputo from January-February 2021. All had routine SARS-CoV-2 PCR testing performed. For patients with positive results, hospital charts were retrospectively reviewed. Descriptive analyses were performed. Results: of 209 patients that had SARS-CoV-2 PCR testing performed, 102 (48.8%) received results, of which 37 (36.3%) were positive. Positive results were received prior to discharge for 14 patients (37.8%). Median duration of hospitalization was 3 days. There were two deaths in COVID-positive patients (5.4%), both with complex comorbidities. For the 35 COVID-19 positive patients whose charts were located, the principal admission diagnosis was respiratory for 22 (62.9%), and 14 (40.0%) had oxygen saturation <94% at admission. The white blood cell count was >12.0 x 103cells/mL in 10 patients (28.6%) and the most common abnormal finding on chest radiograph was peribronchial thickening (38.5% of patients with results). Oxygen therapy was needed for 20 patients (57.1%). Conclusion: the majority of infants with COVID-19 had a mild, short-duration respiratory illness that did not exceed ward capacity for care, including oxygen treatment. Laboratory capacity for PCR testing was overwhelmed, delaying the return of results and complicating inpatient infection control measures.
Asunto(s)
COVID-19 , Femenino , Humanos , Lactante , Niño , COVID-19/diagnóstico , COVID-19/epidemiología , SARS-CoV-2 , Estudios Retrospectivos , Pandemias , Mozambique/epidemiología , OxígenoRESUMEN
Introduction: during the second wave of the COVID-19 pandemic in Mozambique, there was a surge in pediatric hospitalizations at a time when there was relatively little evidence, but significant concern about clinical outcomes in African children, particularly in higher-risk infants requiring, and health system capacity to respond. Methods: a retrospective cohort study was conducted for patients 1-12 months of age admitted to the Breastfeeding ward at Hospital Central de Maputo from January-February 2021. All had routine SARS-CoV-2 PCR testing performed. For patients with positive results, hospital charts were retrospectively reviewed. Descriptive analyses were performed. Results: of 209 patients that had SARS-CoV-2 PCR testing performed, 102 (48.8%) received results, of which 37 (36.3%) were positive. Positive results were received prior to discharge for 14 patients (37.8%). Median duration of hospitalization was 3 days. There were two deaths in COVID-positive patients (5.4%), both with complex comorbidities. For the 35 COVID-19 positive patients whose charts were located, the principal admission diagnosis was respiratory for 22 (62.9%), and 14 (40.0%) had oxygen saturation <94% at admission. The white blood cell count was >12.0 x 103cells/mL in 10 patients (28.6%) and the most common abnormal finding on chest radiograph was peribronchial thickening (38.5% of patients with results). Oxygen therapy was needed for 20 patients (57.1%). Conclusion: the majority of infants with COVID-19 had a mild, short-duration respiratory illness that did not exceed ward capacity for care, including oxygen treatment. Laboratory capacity for PCR testing was overwhelmed, delaying the return of results and complicating inpatient infection control measures.
Asunto(s)
Humanos , Masculino , Femenino , Pediatría , Pruebas Diagnósticas de Rutina , SARS-CoV-2 , COVID-19 , Unidades de Cuidados Intensivos , Reacción en Cadena de la PolimerasaRESUMEN
Hydrocarbon-contaminated environments often also experience co-contamination with elevated levels of salt. This paper investigates the occurrence of halotolerance among several hydrocarbon-degrading bacteria, as an initial assessment of the importance of salt contamination to bioremediation strategies. Halotolerance was common, but not ubiquitous, among the 12 hydrocarbon-degrading bacteria tested, with many strains growing at up to 75 or 100â g NaClâ L(-1) in rich medium. Greater sensitivity to elevated salt concentrations was observed among aromatics degraders compared to saturates degraders, and in defined medium compared to rich medium. Observed effects of high salt concentrations included increased lag times and decreased maximum growth. Many strains exhibited flocculation at elevated salt concentrations, but this did not correlate to any patterns in cell surface hydrophobicity, measured using the Bacterial Adhesion to Hydrocarbon assay. The occurrence of halotolerance in hydrocarbon-degrading bacteria suggests the potential for native microorganisms to contribute to the bioremediation of oil and salt co-contaminated sites, and indicates the need for a better understanding of the relationship between halotolerance and hydrocarbon biodegradation capabilities.
Asunto(s)
Bacterias/metabolismo , Hidrocarburos/metabolismo , Cloruro de Sodio/metabolismo , Microbiología del Suelo , Contaminantes del Suelo/metabolismo , Bacterias/crecimiento & desarrollo , Biodegradación Ambiental , Interacciones Hidrofóbicas e Hidrofílicas , SalinidadAsunto(s)
Papillomavirus Humano 6/aislamiento & purificación , Linfoma de Células B/virología , Papillomaviridae/aislamiento & purificación , Infecciones por Papillomavirus/virología , Neoplasias Cutáneas/virología , Carcinoma de Células de Merkel/virología , Papillomavirus Humano 6/genética , Humanos , Melanoma/virología , Neoplasias de Células Escamosas/virología , Papillomaviridae/genéticaRESUMEN
Introduction of point mutations in the 5' end of the human papillomavirus type 16 (HPV-16) L1 gene specifically inactivates negative regulatory RNA processing elements. DNA vaccination of C57Bl/6 mice with the mutated L1 gene resulted in improved immunogenicity for both neutralizing antibodies as well as for broad cellular immune responses. Previous reports on the activation of L1 by codon optimization may be explained by inactivation of the regulatory RNA elements. The modified HPV-16 L1 DNA that induced anti-HPV-16 immunity may be seen as a complementary approach to protein subunit immunization against papillomavirus.